Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Losartan Potassium NDC 50090-3403 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image - deb2d34c 8675 422d 944e e8026c82f6c2 01
image - deb2d34c 8675 422d 944e e8026c82f6c2 02
This is a comparison of two medications, Atenolol and Losartan, based on the percentage of patients with the primary endpoint. An adjusted risk reduction of 13%, with a p-value of 0.021, was observed. The study was conducted for a period of 66 months, with data collected at regular intervals of 6 months.*
image - deb2d34c 8675 422d 944e e8026c82f6c2 03
This is a chart showing the percentage of patients with fatal or non-fatal strokes during a study of Atenolol versus Losartan over a period of 66 months. The chart also indicates an adjusted risk reduction of 25% for stroke with Losartan compared to Atenolol, with a p-value of 0.001.*
image - deb2d34c 8675 422d 944e e8026c82f6c2 04
This appears to be a table showing the results of a medical study comparing two drugs ("Losartan" and "Atenolol") for stroke prevention in patients who may or may not have diabetes or a history of cardiovascular disease. The table includes information about the number of patients studied, their ages and genders, and the rates of stroke (fatal/non-fatal) experienced by patients in each group. The table also provides hazard ratios and confidence intervals.*
image - deb2d34c 8675 422d 944e e8026c82f6c2 05
Label Image - lbl500903403
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.